MLAB
MESA LABORATORIES INC /CO/
Next earnings Aug 3, 2026 · consensus $0.03 EPS, $62.1M rev
Last earnings -14.5% on 2026-05-27
$102.42
▲ +4.35%$102.42▲ +7.70%
over 1Y
L $57.01EODHDH $109.13
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.4%
1W+9.9%
1M+13.0%
3M+25.0%
YTD+29.4%
1Y+7.7%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Thin net margin (2.7%).
The read
Weak on both the fundamentals and the price — little to like at the current level.
MESA LABORATORIES INC /CO/ shows $249M in FY2026 revenue (+3.4% YoY), a 2.7% net margin, and 3.6% ROE.
Financials · annual, by fiscal year
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $184M | $219M | $216M | $241M | $249M |
| Gross profit | $109M | $134M | $133M | $151M | $158M |
| Operating income | $4.70M | $3.32M | -$272M | $16.3M | $18.5M |
| Net income | $1.87M | $930K | -$254M | -$1.97M | $6.71M |
| Diluted EPS | $0.35 | $0.17 | -$47.20 | -$0.36 | $1.21 |
| Net margin | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$609M
EV / EBITDA11.6
EV / Sales2.4
EV / FCF15.4
P / FCF14.3
PEG (trailing)0.19
Earnings yield1.2%
FCF yield7.0%
Quality & risk
ROIC (est.)5.7%
Free cash flow$39.6M
Total debt$69.6M
Net cash-$42.7M
Altman Z-Score1.65 distress
Piotroski F-Score8/9
Capital returns
Buyback yield0.0%
Dividend yield (est.)0.6%
Shareholder yield0.6%
Shares Δ YoY+1.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-182026-06-23open ↗144Filing2026-06-22open ↗144Filing2026-06-22open ↗4Period ending 2026-06-162026-06-17open ↗4Period ending 2026-06-162026-06-17open ↗4Period ending 2026-06-162026-06-17open ↗3Period ending 2026-06-152026-06-16open ↗144Filing2026-06-16open ↗144Filing2026-06-16open ↗144Filing2026-06-16open ↗
Frequently asked
- Is MESA LABORATORIES INC /CO/ (MLAB) a buy?
- MLAB currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Thin net margin (2.7%).
- What is MLAB's fair value?
- A Modified-Graham model based on MLAB's SEC fundamentals estimates a fair value of about $42.93. It is an estimate from reported earnings, not a price target.
- Is MLAB overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, MLAB currently appears overvalued relative to its SEC-grounded earnings power.
- What is MESA LABORATORIES INC /CO/'s quality score?
- MLAB scores 61.431372549019606/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000724004, latest 10-K filed 2026-06-03) · EODHD · as of 6/26/2026, 1:09:27 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.